MentionFox
Home › funding signals › HCW Biologics Inc.
Form D · on the record

HCW Biologics Inc. — $6.92M Form D filing, December 2024

Before you sell to, join or invest in HCW Biologics Inc.

MentionFox check on HCW Biologics Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/hcw-biologics-inc-form-d-24000001

Check HCW Biologics Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about HCW Biologics Inc.?

HCW Biologics Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-05.

HCW Biologics Inc. filed a Form D notice of an exempt securities offering with the SEC on December 5, 2024. HCW Biologics Inc. trades on Nasdaq as HCWB. The filing reports $6.92M sold. Its industry group is Biotechnology. It names Hing Wong (Executive Officer, Director), Rebecca Byam (Executive Officer), Peter Rhode (Executive Officer) (SEC Form D, December 5, 2024).

In its own words: “TRANSFORMATIVE FUSION IMMUNOTHERAPEUTICS REVOLUTIONARY TREATMENTS FOR AUTOIMMUNE DISEASES, CANCER AND SENESCENCE-ASSOCIATED DYSPLASIA TRANSFORMATIVE.” (hcwbiologics.com, checked November 1, 2026)

Is this your company?

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

Key facts

Run the free check on HCW Biologics Inc. →

Sell to companies like HCW Biologics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

HCW Biologics Inc.

New Form D on file · 2024-12-05 · the record

$6.92M
raise on the record
D
filing
1
investors in
FLORIDA
based
Open the record →

What the record says

FilingForm D
Filed2024-12-05
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedMIRAMAR, FLORIDA
CIK1828673
Accession0001828673-24-000002

Pitching, partnering or investing alongside them? See who really runs and owns HCW Biologics Inc.

Watch HCW Biologics Inc.: email me the next time it files something

Free to see. No signup.

What do you want to do with HCW Biologics Inc.?

Get the full cited report on HCW Biologics Inc.

What the filing shows about HCW Biologics Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 8 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on HCW Biologics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives HCW Biologics Inc.'s address as 2929 N Commerce Pkwy, Miramar, FL 33025.

Full funding history for HCW Biologics Inc. →

What the filing says

  • Offered: $6,918,254. Sold: $6,918,254. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: November 20, 2024. (filing)
  • Types of securities: Options, warrants or other rights to acquire another security. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Offering amount represents total proceeds from a concurrent registered direct offering of shares of the issuer's common stock & pre-funded warrants to purchase shares of common stock and a private offering of warrants to purchase shares of common stock.” (filing)
  • On sales commissions and finders' fees: the filing adds “Unregistered warrants part of a larger offering with registered shares of common stock and pre-funded warrants, with Maxim Group as placement agent. Maxim will not receive compensation for unregistered warrants.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on HCW Biologics Inc. See pricing

Is HCW Biologics Inc. a real, registered company?

HCW Biologics Inc. is a registered filer with the SEC (CIK 1828673) and has filed since 2024-02-27. 5 filings are on record, the latest on 2026-10-08.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs HCW Biologics Inc.?

HCW Biologics Inc.'s Form D of 2024-12-05 names Hing Wong, Rebecca Byam, Peter Rhode and 5 more as its officers, directors or promoters.

How much has HCW Biologics Inc. raised?

Its new offerings report $16.52M sold across 5 offerings, as its own filings state.

Filing history · 5 filings on this registrant
Form D · 2024-02-27 · $2.50MForm D · 2024-12-05 · $6.92M · this pageForm D · 2026-06-08 · $4MForm D · 2026-08-06 · $1.60MForm D · 2026-10-08 · $1.50M 2024-02-27 2026-10-08

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week

Trailing twelve months. 763 filings in Biotechnology, totalled by week.

Want the whole picture on HCW Biologics Inc.?

What the filing shows about HCW Biologics Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 8 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on HCW Biologics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on HCW Biologics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind HCW Biologics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for HCW Biologics Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

HCW Biologics Inc.: Raised $6.92M, Form D filed 2024-12-05
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/hcw-biologics-inc-form-d-24000001
Last updated 2026-11-08
Primary record: SEC filing 1 · SEC filing 2
HCW Biologics Inc. raised $6.92M — SEC Form D filing, December 2024. MentionFox, 2026-11-08. https://mentionfox.com/funding/hcw-biologics-inc-form-d-24000001